New Delhi’s pharmaceutical landscape is buzzing with optimism as India’s API market, worth $15-16 billion today, projects 5-7% CAGR through…
New Delhi’s pharmaceutical landscape is buzzing with optimism as India’s API market, worth $15-16 billion today, projects 5-7% CAGR through…
In the midst of trade negotiations between India and the United States, one sector stands out with unshakeable confidence: pharmaceuticals.…